Mototsugu Shimokawa

Also affiliated with Yamaguchi University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer”.

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02482-7

N/A

0.211DataRank · unranked

3 citations

Naoki Haratake, Atrayee Bhattacharya, Chie Kikutake, Hiroki Ozawa, Keisuke Shigeta +15 more

192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study

Annals of Oncology(2020)10.1016/j.annonc.2020.10.456

N/A

0DataRank · unranked

1 citations

Haruo Iguchi, Mototsugu Shimokawa, Tsuyoshi Shirakawa, F. Koga, Yujiro Ueda +14 more

A PHASE 2 TRIAL OF CHOP WITH ANTI‐CCR4 ANTIBODY MOGAMULIZUMAB FOR ELDERLY PATIENTS WITH CCR4‐POSITIVE ADULT T‐CELL LEUKEMIA/LYMPHOMA

Hematological Oncology(2023)10.1002/hon.3163_125

N/A

0DataRank · unranked

0 citations

Shigeru Kusumoto, Ilseung Choi, Makoto Yoshimitsu, Mototsugu Shimokawa, Yutaka Suehiro +25 more

IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0011

N/A

0DataRank · unranked

5 citations

Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang +13 more